TY - JOUR
T1 - Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type
T2 - A case series and review of the literature
AU - Winkler, Manuel
AU - Albrecht, Jana Dorothea
AU - Sauer, Christian
AU - Kordaß, Theresa
AU - Guenova, Emmanuella
AU - Livingstone, Elisabeth
AU - Wobser, Marion
AU - Mitteldorf, Christina
AU - Géraud, Cyrill
AU - Nicolay, Jan Peter
N1 - © 2024 The Author(s). The Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association.
PY - 2024/9
Y1 - 2024/9
N2 - Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL, LT) is a subtype of cutaneous B-cell lymphoma with unfavorable prognosis usually requiring aggressive polychemotherapy for disease control. Only single cases of spontaneous regression of PCDLBCL, LT are reported in the literature, peaking 3 months post-biopsy following a clinical history of no longer than 1 year. Here, we report the first case of a spontaneously relapsing and remitting PCDLBCL, LT with complete regression after a clinical history of more than 9 years and thus an atypically indolent clinical course. The female patient presented with recurrent erythematous, non-ulcerated, non-raised plaques of the right lower leg for 6 years. Pathological workup and exclusion of a systemic disease confirmed the diagnosis of PCDLBCL, LT. Due to the history of repeated spontaneous remission, no therapy was initiated. Nine years after first occurrence the patient presented with complete clinical remission lasting for 64 months. We retrospectively identified four additional PCDLBCL, LT patients with spontaneous remission lasting up to 53 months. Our data provide evidence for a distinct PCDLBCL, LT patient subgroup that clinicians should be aware of and warrants a watch-and-wait treatment regime.
AB - Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL, LT) is a subtype of cutaneous B-cell lymphoma with unfavorable prognosis usually requiring aggressive polychemotherapy for disease control. Only single cases of spontaneous regression of PCDLBCL, LT are reported in the literature, peaking 3 months post-biopsy following a clinical history of no longer than 1 year. Here, we report the first case of a spontaneously relapsing and remitting PCDLBCL, LT with complete regression after a clinical history of more than 9 years and thus an atypically indolent clinical course. The female patient presented with recurrent erythematous, non-ulcerated, non-raised plaques of the right lower leg for 6 years. Pathological workup and exclusion of a systemic disease confirmed the diagnosis of PCDLBCL, LT. Due to the history of repeated spontaneous remission, no therapy was initiated. Nine years after first occurrence the patient presented with complete clinical remission lasting for 64 months. We retrospectively identified four additional PCDLBCL, LT patients with spontaneous remission lasting up to 53 months. Our data provide evidence for a distinct PCDLBCL, LT patient subgroup that clinicians should be aware of and warrants a watch-and-wait treatment regime.
KW - Female
KW - Humans
KW - Biopsy
KW - Leg/pathology
KW - Lymphoma, Large B-Cell, Diffuse/pathology
KW - Neoplasm Regression, Spontaneous
KW - Remission, Spontaneous
KW - Skin/pathology
KW - Skin Neoplasms/pathology
UR - https://www.scopus.com/pages/publications/85198857208
U2 - 10.1111/1346-8138.17339
DO - 10.1111/1346-8138.17339
M3 - Article
C2 - 39031169
SN - 0385-2407
VL - 51
SP - 1233
EP - 1239
JO - The Journal of dermatology
JF - The Journal of dermatology
IS - 9
ER -